ORPHA:99084
Peripheral pulmonary stenosis
Also known as: Branch pulmonary artery stenosis · Pulmonary branch stenosis
Publications
1,172
Trials
1
Interventional, condition-specific
Researchers
1,174
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
Peripheral pulmonary stenosis is a rare anomaly of the great arteries that may occur at single or multiple sites, in isolation or in association with other heart defects (valvular pulmonary stenosis, atrial, or ventricular septal defects or tetralogy of Fallot) and genetic syndromes (Williams, Alagile syndrome). Clinical presentation is variable and includes heart murmurs, dyspnea, syncope, chest pain and pulmonary hypertension-associated symptoms.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0020420
- UMLS:C3531782
- NCIT:C99144
Additional Mondo synonyms (2)
branch pulmonary artery stenosis · pulmonary artery stenosis, branch (not PPS)
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,172 matched papers (571 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
1 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,172
1,172 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,172 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
571 in the last 10 years · low confidence
Phrase hits: 1,172 · MeSH hits: 0
Who's working on it?
1,174
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Lamers L4 papers · 2022
Pediatrics, Division of Cardiology, University of Wisconsin - Madison, Madison, WI, USA.
Papers in Europe PMC - 02Pewowaruk R4 papers · 2022
Biomedical Engineering, University of Wisconsin - Madison, Madison, WI, USA.
Papers in Europe PMC - 03Roldán-Alzate A4 papers · 2022
Biomedical Engineering, University of Wisconsin - Madison, Madison, WI, USA. roldan@wisc.edu.
Papers in Europe PMC - 04Zhang X4 papers · 2025
Department of Cardiac Surgery, Zhejiang University Sir Run Run Shaw Hospital, Zhejiang, China. drzhangxiaojie@zju.edu.cn.
Papers in Europe PMC - 05Alwi M3 papers · 2023
Department of Pediatric Cardiology, Institut Jantung Negara (National Heart Institute) 50400 Kuala Lumpur, Malaysia.
Papers in Europe PMC - 06Çiçek M3 papers · 2025
Department of Pediatric Cardiovascular Surgery, University of Health Sciences Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
Papers in Europe PMC - 07Hekim Yılmaz E3 papers · 2025
Department of Pediatric Cardiology, University of Health Sciences Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
Papers in Europe PMC - 08Hiremath G3 papers · 2024
Department of Pediatrics, Masonic Children's Hospital, University of Minnesota, Minneapolis, Minnesota. Electronic address: hiremath@umn.edu.
Papers in Europe PMC - 09Huang Y3 papers · 2024
Department of Cardiovascular Pediatrics, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, P.R. China.
Papers in Europe PMC - 10Korun O3 papers · 2025
Department of Pediatric Cardiovascular Surgery, University of Health Sciences Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1
interventional trials for this specific condition
1 interventional trial matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026
1 interventional trial — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 80.1th percentile).
low confidence · 80.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 18 · after dedupe 18 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 18 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (18)
- isrctn·ISRCTN25686858·Recruiting·Effect of evidence-driven computerised rule-guided exercise prescription combined with closed-loop remote supervision
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14598016·Recruiting·Testing a novel home-based approach for strengthening motor pathways
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN94574860·Suspended·Comparing once-daily combination inhalers with tiotropium to find which helps people with chronic obstructive pulmonary disease exercise longer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN94603622·Recruiting·Investigating the use of oral imatinib as a treatment for pulmonary arterial hypertension
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14164179·Stopped·A study to test the safety and effectiveness of using mutant pro-urokinase and low-dose alteplase to unblock blood vessels in heart attack patients before receiving treatment at a hospital with PCI capability
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12192375·Recruiting·Longitudinal physiological changes in inherited metabolic disorders
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14603929·No longer recruiting·A feasibility study of using a novel lifestyle change programme (Super Rehab) to reverse coronary artery disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN67799751·No longer recruiting·Observational study assessing early markers of high blood pressure mediated brain damage and the impact of single-pill treatment with Perindopril/Indapamide
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN80181257·Stopped·Application of autologous peripheral blood-derived stem cell/progenitor cell (CD34+) + stem cells and hyperbaric oxygen therapy for patients with severe limb ischemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14618196·No longer recruiting·Increase of adenosine doses in fractional flow reserve
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN91147138·No longer recruiting·A prospective, nonrandomized, noninterventional study to compare Nexfin CO-trek cardiac output with thermodilution cardiac output
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN40973936·No longer recruiting·Pregnancy and chronic hypertension; nifedipine or labetalol as anti-hypertensive treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN04708680·No longer recruiting·Early treatment of atrial fibrillation for stroke prevention trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84724990·No longer recruiting·Coronary artery bypass graft (CABG) off- or on-pump revascularisation study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN42524037·No longer recruiting·Exercise training in Diastolic Heart Failure - Pilot study: a prospective, randomised, controlled study to determine the effects of physical training on exercise capacity and quality of life
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN27178415·No longer recruiting·Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertension
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN45687883·No longer recruiting·A prospective multicentre double blind placebo controlled trial to evaluate the effectiveness of patent foramen ovale (PFO) closure with the STARFlex® septal repair implant to resolve refractory migraine headache
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66274524·No longer recruiting·Accelerating the development and implementation of DNA damage inhibitor and radiotherapy treatment (with or without immunotherapy) in head and neck squamous cell carcinoma
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Peripheral pulmonary stenosis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Peripheral pulmonary stenosis" OR "Branch pulmonary artery stenosis" OR "Pulmonary branch stenosis" OR "pulmonary artery stenosis, branch (not PPS)"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Peripheral pulmonary stenosis" OR "Branch pulmonary artery stenosis" OR "Pulmonary branch stenosis" OR "pulmonary artery stenosis, branch (not PPS)"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1172) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T05:59:42.541Z
